Reportee | Signature Date | Report period | Total Entries | Total AUM($) |
---|---|---|---|---|
BAKER BROS ADVISORS LP | 11-14-2023 | 09-30-2023 | 101 | 17,351,037,330 |
Issuer | Class | Position | Value | Shares | Portfolio Percentage (%) | Previous Percentage (%) | Shares Delta | Shares Delta(%) | Date Reported |
---|---|---|---|---|---|---|---|---|---|
Xencor, Inc. | COM | 151 | $2,481,009 | 123,127 | 0.00 | 123,127 | +Inf | 09-30-2023 | |
KALA BIO, Inc. | COM | 152 | $2,372,856 | 266,613 | 0.00 | 266,613 | +Inf | 09-30-2023 | |
Achilles Therapeutics plc | SPONSORED ADS | 153 | $2,326,750 | 2,557,149 | 0.00 | 0.04 | -34,217 | -1.32 | 09-30-2023 |
Century Therapeutics, Inc. | COM | 154 | $2,298,680 | 1,149,340 | 0.00 | 0.02 | 778,753 | 210.14 | 09-30-2023 |